Syncom Formulations (India) has informed about submission of Revised Standalone Unaudited Financial Results along with Limited Review Report thereon by Statutory Auditors for Quarter/ Half-Year ended on 30th September, 2017 in accordance with Regulation 33 of the SEBI (LODR) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1625.00 |
| Dr. Reddys Lab | 1308.05 |
| Cipla | 1288.40 |
| Zydus Lifesciences | 925.60 |
| Lupin | 2307.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: